ライフサイエンスコーパス: cardiac catheterization

1 conventional cardiac angiography (hereafter, cardiac catheterization).

2 ocardiography, radionuclide scintigraphy, or cardiac catheterization).

3 aried markedly across facilities (<1->95% of cardiac catheterizations).

4 uent and life-threatening complication after cardiac catheterization.

5 partly through barriers in timely access to cardiac catheterization.

6 on patient dose and operator exposure during cardiac catheterization.

7 ly reduce operator radiation exposure during cardiac catheterization.

8 patients with atrial fibrillation undergoing cardiac catheterization.

9 atures and outcome of LFLG-AS assessed using cardiac catheterization.

10 scretion of the invasive cardiologist during cardiac catheterization.

11 itate myocardial viability assessment during cardiac catheterization.

12 2)) without other valvular disease underwent cardiac catheterization.

13 low predicted probability of CAD undergoing cardiac catheterization.

14 med coronary artery disease (CAD) undergoing cardiac catheterization.

15 n = 587 total) from RNA samples collected at cardiac catheterization.

16 and HFpEF (n = 83), determined invasively by cardiac catheterization.

17 will not have an occluded culprit artery at cardiac catheterization.

18 ith atrial fibrillation on OAC who underwent cardiac catheterization.

19 coronary artery bypass surgery (CABG) after cardiac catheterization.

20 st 400 underwent coronary CT angiography and cardiac catheterization.

21 repository of sequential patients undergoing cardiac catheterization.

22 e to a programming error that did not prompt cardiac catheterization.

23 Doppler echocardiography in comparison with cardiac catheterization.

24 terization; and late VT/VF, after the end of cardiac catheterization.

25 o underwent (18)F-FDG PET/CT and concomitant cardiac catheterization.

26 ome more prevalent among patients undergoing cardiac catheterization.

27 low-up in 1,010 subjects undergoing elective cardiac catheterization.

28 ti-year, multicenter cohort of strokes after cardiac catheterization.

29 factor receptor-2 in 110 patients undergoing cardiac catheterization.

30 en states with and without CON regulation of cardiac catheterization.

31 nts with coronary atherosclerosis undergoing cardiac catheterization.

32 secutive aspirin-treated patients undergoing cardiac catheterization.

33 ed myocardial ischemia who were referred for cardiac catheterization.

34 ents (2,729 in a training set) who underwent cardiac catheterization.

35 sus moderate and severe CoA as determined by cardiac catheterization.

36 ent advances in non-interventional pediatric cardiac catheterization.

37 n the radial artery becomes obstructed after cardiac catheterization.

38 issing data regarding race or the diagnostic cardiac catheterization.

39 least 65 years old and undergoing diagnostic cardiac catheterization.

40 raphy in 234 patients undergoing transradial cardiac catheterization.

41 wall might be damaged after cannulation for cardiac catheterization.

42 orted by echocardiography when compared with cardiac catheterization.

43 ease risk in a cohort of patients undergoing cardiac catheterization.

44 red by a method previously validated against cardiac catheterization.

45 erse outcomes in children with PH undergoing cardiac catheterization.

46 tomy, cardiac treatments, and outcomes after cardiac catheterization.

47 of experiencing a major adverse event after cardiac catheterization.

48 in rates per 1000 CHD patients in diagnostic cardiac catheterizations (11.7 to 13.7 per 1000), struct

49 II Registry from 2013 to 2016, 741 underwent cardiac catheterization (139 with percutaneous coronary

50 d with an increased likelihood of subsequent cardiac catheterization (22.9% vs 12.1%; adjusted odds r

51 CATHGEN biorepository of patients undergoing cardiac catheterization; 254 families (N = 827 individua

52 ss test (n=60: stress echo [62%], CMR [32%], cardiac catheterization [3%], nuclear [2%], and coronary

53 ; P < .001), and were less likely to undergo cardiac catheterization (33.8% vs 77.8%; AOR, 0.19; 95%

54 ved less aggressive interventions, including cardiac catheterization (60.7% versus 54.0%; P<0.001), p

55 cularization strategy was similar to that of cardiac catheterization; accordingly, coronary CT angiog

56 settings of coronary artery bypass grafting, cardiac catheterization, acute myocardial infarction, co

57 s in whom CABG was performed </= 1 day after cardiac catheterization (adjusted mean rates [95% CI]: 2

58 chanical circulatory support within 1 day of cardiac catheterization after adjustment for patient- an

59 er rates of equivocally and weakly indicated cardiac catheterization after admission for acute myocar

60 was to examine whether rates of appropriate cardiac catheterization after admission for acute myocar

61 Patients were more likely to undergo cardiac catheterization after computed tomography angiog

62 ed sixty-one adult Fontan patients underwent cardiac catheterization; age 26+/-3 years, men 146 (56%)

63 These progressively supplant the use of cardiac catheterization, although the value of myocardia

64 Associations between nSES and receipt of cardiac catheterization and 30-day mortality were noted

65 ,110,150 patients undergoing only diagnostic cardiac catheterization and 941,248 undergoing percutane

66 muscularization as assessed by closed-chest cardiac catheterization and anti-alphaSMA staining.

67 the need for new dialysis) and time between cardiac catheterization and CABG was evaluated using mul

68 ely and modestly related to the time between cardiac catheterization and CABG, with the highest incid

69 (range, 0.45-16.5 years) underwent combined cardiac catheterization and cardiovascular magnetic reso

70 phs represented 92% of examinations, whereas cardiac catheterization and computed tomography accounte

71 y of 3 key bleeding avoidance strategies for cardiac catheterization and coronary procedural (radial

72 lusion criteria included the need for urgent cardiac catheterization and history of ACS or coronary r

73 n from the renal vein of patients undergoing cardiac catheterization and identified glycerol-3-phosph

74 titutions in 54 pediatric PH patients during cardiac catheterization and in 54 matched controls.

75 titutions in 78 pediatric PH patients during cardiac catheterization and in 78 matched controls.

76 ediatric and Adult Congenital Treatment) for cardiac catheterization and intervention for pediatric a

77 sepsis, acute heart failure, and receipt of cardiac catheterization and mechanical ventilation accou

78 Although post-imaging use of cardiac catheterization and medical therapy increased in

79 elationships between nSES and the receipt of cardiac catheterization and mortality after acute corona

80 association between nSES and the receipt of cardiac catheterization and mortality after an acute cor

81 those tested, only 11% underwent subsequent cardiac catheterization and only 5% underwent repeat rev

82 first operator radiation dose during routine cardiac catheterization and percutaneous coronary interv

83 udy comparing operator radiation dose during cardiac catheterization and percutaneous coronary interv

84 ines for risk stratification of patients for cardiac catheterization and possible percutaneous corona

85 Women also experienced lower use of cardiac catheterization and revascularization procedures

86 luding the use of interventional procedures (cardiac catheterization and revascularization procedures

87 al variable to study the impact of timing of cardiac catheterization and revascularization therapy on

88 The use of cardiac catheterization and revascularization was higher

89 Although overall rates of cardiac catheterization and revascularization were simil

90 n early invasive treatment strategy (routine cardiac catheterization and revascularization when appro

91 patients without obstructive CAD who undergo cardiac catheterization and to inform decision making re

92 evaluated by concurrent echocardiography and cardiac catheterization and traditionally does not accou

93 ds (IGR, cardiac magnetic resonance imaging, cardiac catheterization, and echocardiography) and index

94 performed in 54 pediatric PH patients during cardiac catheterization, and in 54 matched controls.

95 e of ablation with hemodynamic assessment by cardiac catheterization, and LA/LV structure and functio

96 gram scans, radionuclide imaging, diagnostic cardiac catheterization, and percutaneous coronary inter

97 Blood samples were collected during cardiac catheterization, and plasma levels of IL-18 and

98 We identified stress testing, cardiac catheterization, and revascularization procedure

99 We performed baseline echocardiographic, cardiac catheterization, and serum NT-pro-BNP analysis i

100 /VF any time; early VT/VF, before the end of cardiac catheterization; and late VT/VF, after the end o

101 re (AOR, 0.85; 95% CI, 0.79-0.92), and prior cardiac catheterization (AOR, 0.45; 95% CI, 0.38-0.54) w

102 ation of end-diastolic pressures obtained by cardiac catheterization are necessary for the diagnosis

103 Longitudinal follow-up and confirmation by cardiac catheterization are warranted.

104 their diagnostic accuracy was compared, with cardiac catheterization as the reference standard.

105 hours) therapies and early (first 48 hours) cardiac catheterization as well as in-hospital major ble

106 21 years of age with PH undergoing 1 or more cardiac catheterization at centers participating in the

107 e cohort, 278 symptomatic patients underwent cardiac catheterization at our institution an average of

108 tion of networks to provide around-the-clock cardiac catheterization availability and the generation

109 This large cardiac catheterization-based study reports that the LFL

110 ingly adopted as the primary access site for cardiac catheterization because of patient preference, l

111 We evaluated 107 patients with cardiac catheterization before and immediately following

112 ents undergoing diagnostic or interventional cardiac catheterization between January 2011 and March 2

113 936 veterans (3181 women) undergoing initial cardiac catheterization between October 1, 2007, and Sep

114 h stable ischemic heart disease confirmed on cardiac catheterization between October 1, 2008, and Sep

115 ry of cardiac disease who underwent elective cardiac catheterization between October 1, 2008, and Sep

116 ed differences in the use of CABG, PTCA, and cardiac catheterization between white versus black and H

117 Contrast media administered during cardiac catheterization can affect hemodynamic variables

118 Skills required to perform cardiac catheterization can be learned via mentored simu

119 When needed, cardiac magnetic resonance and cardiac catheterization can be obtained.

120 model for adverse outcomes after congenital cardiac catheterization can support reporting of risk-ad

121 its (380 [30.0%] vs 2581 [74.4%], P < .001), cardiac catheterization capabilities (6 [0.5%] vs 1654 [

122 ital coronary artery bypass graft surgery or cardiac catheterization capability.

123 n (MI) incidence with increased frequency of cardiac catheterization (CATH) in liver transplant (LT)

124 Non-interventional pediatric cardiac catheterization continues to have an important r

125 Cardiac catheterization, coronary revascularization, acu

126 ed with CAD, we retrospectively analyzed the cardiac catheterization data of 97 asymptomatic type 1 a

127 ies were assessed with echocardiographic and cardiac catheterization data.

128 ging-derived CI (r=0.7; P<0.001), as well as cardiac catheterization-derived CI (r=0.6; P<0.001).

129 implications for technical considerations of cardiac catheterization, design of the catheterization l

130 incidence in those operated </= 1 day after cardiac catheterization despite their lower risk profile

131 hs to 25 years of age presenting for routine cardiac catheterization during 2015 to 2016.

132 ion on oral anticoagulation (OAC) undergoing cardiac catheterization face risks for embolic and bleed

133 surgery should be planned in a hospital with cardiac catheterization facilities.

134 seventy-four patients undergoing nonemergent cardiac catheterization followed by treatment (ie, 128 c

135 n stable patients having elective diagnostic cardiac catheterization for 1-year risks of death and MI

136 ta were obtained from 50 patients undergoing cardiac catheterization for clinical indications.

137 he occurrence of a major adverse event after cardiac catheterization for congenital heart disease.

138 d children undergoing a clinically indicated cardiac catheterization for evaluation of PAH and pulmon

139 From 1996 to 2008, 58 patients underwent cardiac catheterization for FM, with intervention perfor

140 rospective review of all patients undergoing cardiac catheterization for FM.

141 high-dose clopidogrel in patients undergoing cardiac catheterization for planned percutaneous coronar

142 raphy) study, 371 patients underwent CTA and cardiac catheterization for the detection of obstructive

143 Patients underwent biventricular EMB, cardiac catheterization (for exclusion of coronary arter

144 The timing of cardiac catheterization, for whom catheterization is ind

145 ted probability of obstructive CAD underwent cardiac catheterization; for example, only 19.3% (95% CI

146 without known disease who underwent elective cardiac catheterization had obstructive coronary artery

147 The field of cardiac catheterization has evolved, performing more int

148 ors to improve skills relevant to performing cardiac catheterization has not been evaluated.

149 sensitization procedure was performed before cardiac catheterization in all patients, except for thos

150 d [Pyr(1)]apelin-13 were assessed by MRI and cardiac catheterization in anesthetized rats.

151 more recent advances in echocardiography and cardiac catheterization in assessment of aortic stenosis

152 The risk of cardiac catheterization in children and young adults wit

153 dren) vs low-dose UFH (50 U/kg bolus) during cardiac catheterization in children.

154 (95% CI, 18.7%-19.9%) of patients undergoing cardiac catheterization in New York had a greater than 5

155 th stable coronary artery disease undergoing cardiac catheterization in New York State between 2003 a

156 ovincial registry of all patients undergoing cardiac catheterization in Ontario, to evaluate patients

157 currence of VT/VF before or after the end of cardiac catheterization in patients presenting for prima

158 ions and to increase the diagnostic yield of cardiac catheterization in routine clinical practice.

159 t to fulfill its promise to replace invasive cardiac catheterization in selected patient populations.

160 We identified adult patients who underwent cardiac catheterization including coronary angiography b

161 mine the efficacy of the MXPD during routine cardiac catheterization, including percutaneous coronary

162 ested that the time to cardiac surgery after cardiac catheterization is inversely related to postoper

163 dization for adverse events after congenital cardiac catheterization is needed to equitably compare p

164 Cardiac output during cardiac catheterization is often estimated using the mod

165 Cardiac catheterization is performed in moderate- and hi

166 Cardiac catheterization is routinely used as a diagnosti

167 Cardiac catheterization is the standard of care procedur

168 Procedures in the cardiac catheterization lab are more complex, take longe

169 As the cardiac catheterization lab continues to evolve, the dem

170 The cardiac catheterization lab has concerns for both patien

171 The role of the anesthesiologist in the cardiac catheterization lab must be defined in this chan

172 iologist is becoming an integral part of the cardiac catheterization lab team, and an important eleme

173 mal complications in the evolving modern day cardiac catheterization lab.

174 sessment, Reporting, and Tracking System for Cardiac Catheterization Laboratories (CART-CL) program.

175 fluoroscopic exposure rates in contemporary cardiac catheterization laboratories (CCL).

176 collects data from approximately 85% of the cardiac catheterization laboratories in the United State

177 Interventional cardiologists at 2 cardiac catheterization laboratories within the same hea

178 states that had weak or no regulation of new cardiac catheterization laboratories, and in wealthier a

179 nd quality improvement activity performed in cardiac catheterization laboratories, but best practices

180 greement exists about whether hospitals with cardiac catheterization laboratories, but without onsite

181 acking (CART) program representing all 76 VA cardiac catheterization laboratories, we evaluated all p

182 ST-segment elevation myocardial infarction, cardiac catheterization laboratory (CCL) activation by e

183 ith a novel protocol of early transport to a cardiac catheterization laboratory (CCL) for extracorpor

184 Rapid activation of a cardiac catheterization laboratory (CCL) has reduced doo

185 ing nurses from intensive care units for the cardiac catheterization laboratory (lower by 0.44 percen

186 above the median OxPL/apoB presented to the cardiac catheterization laboratory a mean of 3.9 years e

187 The frequency of false-positive cardiac catheterization laboratory activation for suspec

188 d leads to increased rates of false-positive cardiac catheterization laboratory activation, unnecessa

189 hin Cardiac ARIA 1A locations (hospital with cardiac catheterization laboratory and all aftercare wit

190 cific ischemia will be the gatekeeper to the cardiac catheterization laboratory and will transform th

191 assessment of coronary artery disease in the cardiac catheterization laboratory are reviewed.

192 ble method predicts periprocedural MI in the cardiac catheterization laboratory before it occurs.

193 A cardiac catheterization laboratory database used by 19 h

194 Particular adaptations to the cardiac catheterization laboratory environment are requi

195 g cardiopulmonary resuscitation [CPR] to the cardiac catheterization laboratory for ECPR) compared wi

196 s and outcomes in patients presenting to the cardiac catheterization laboratory for myocardial infarc

197 allowing for patient triage directly to the cardiac catheterization laboratory from the field.

198 approval process for developing an HOR in a cardiac catheterization laboratory in a VA designated fo

199 ergency department physician to activate the cardiac catheterization laboratory is a key strategy to

200 For these patients, early access to the cardiac catheterization laboratory is associated with a

201 The incidence of CIHB in the pediatric cardiac catheterization laboratory is low at 2.2%.

202 hibitors for selective administration in the cardiac catheterization laboratory only to patients unde

203 All procedures were performed within a cardiac catheterization laboratory or hybrid operating r

204 pharmaco-invasive strategy, and the risk of cardiac catheterization laboratory provider infection re

205 0 minutes, and scene departure to patient on cardiac catheterization laboratory table </=30 minutes.

206 th a time from scene departure to arrival on cardiac catheterization laboratory table of </=30 minute

207 atching, the median time from arrival in the cardiac catheterization laboratory to first balloon was

208 ar function are not readily available in the cardiac catheterization laboratory.

209 ative approaches of late or no access to the cardiac catheterization laboratory.

210 routinely performed post-operatively in the cardiac catheterization laboratory.

211 or introducing a second anticoagulant in the cardiac catheterization laboratory.

212 ain benefits from therapies available in the cardiac catheterization laboratory.

213 e reasons as to why we still need BMS in our cardiac catheterization laboratory.

214 nd 1:118 in participants ascertained via the cardiac catheterization laboratory.

215 nd management of CI-AKI as it applies to the cardiac catheterization laboratory.

216 ation of patients prior to activation of the cardiac catheterization laboratory.

217 Department, Emergency Medical System and the Cardiac Catheterization Laboratory; and 4) Regional STEM

218 MR is complementary and the role of invasive cardiac catheterization may be diminishing.

219 patients with atrial fibrillation undergoing cardiac catheterization, most cases are elective, perfor

220 Cardiac catheterization (n=122, 36%) demonstrated a mean

221 In subjects undergoing cardiac catheterization (n=2597), we identified cases wi

222 studied echocardiographically (n=23) and by cardiac catheterization (n=5) after primary repair (n=4)

223 The primary outcome was cardiac catheterization not leading to revascularization

224 METHODS AND Acute infarction was induced by cardiac catheterization of domestic swine.

225 tion or anesthesia for radiological imaging, cardiac catheterization, office-based surgery, and pedia

226 re referred because of equivocal findings at cardiac catheterization or echocardiography; in one, the

227 ion imaging to determine subsequent rates of cardiac catheterization or noninvasive imaging.

228 adial and femoral access in women undergoing cardiac catheterization or percutaneous coronary interve

229 eath, nonfatal myocardial infarction, repeat cardiac catheterization, or repeat CABG, there was a tre

230 ysis remains unestablished in the setting of cardiac catheterization, owing to unique concerns regard

231 clinical ELISAs using 72 plasma samples from cardiac catheterization patients.

232 invasive reference central BP waveforms from cardiac catheterization patients.

233 tion (primary outcome), invasive management (cardiac catheterization, PCI, or CABG), revascularizatio

234 York State (New York) perform twice as many cardiac catheterizations per capita as those in Ontario

235 Reduced rates of cardiac catheterization, percutaneous coronary intervent

236 Post baseline cardiac catheterization performance assessment, 27 cardi

237 Cardiac catheterization performance was reassessed 1 wee

238 We reviewed 210 700 cardiac catheterizations performed over a 35-year period

239 st incorporating only variables known before cardiac catheterization (pre-PCI model), and the second

240 Of 457 170 cardiac catheterization procedures among 336 853 patient

241 of major complications related to diagnostic cardiac catheterization procedures are extremely rare.

242 Ischemic strokes after cardiac catheterization procedures, although uncommon, l

243 patients scheduled for electrophysiology and cardiac catheterization procedures.

244 The C3PO-QI (Congenital Cardiac Catheterization Project on Outcomes - Quality Im

245 This study examined short-term cardiac catheterization rates and medication changes aft

246 Cardiac catheterization rates varied substantially acros

247 Guidelines for triaging patients for cardiac catheterization recommend a risk assessment and

248 Patients were drawn from the cardiac catheterization registry of the Intermountain He

249 Blacks were also less likely to receive cardiac catheterization, revascularization procedures, o

250 left-side irradiated patients also underwent cardiac catheterization revealing 12 of 13 with coronary

251 1 (access to principal referral center with cardiac catheterization service </=1 hour) to 8 (no ambu

252 Cardiac catheterization, standard lung function testing

253 Analysis of serial cardiac catheterization studies showed that RV and LV fi

254 tudies in animals and in patients undergoing cardiac catheterization suggest that cocaine constricts

255 on Acute kidney injury was more common after cardiac catheterization than after CT angiography in thi

256 Secondary end points included invasive cardiac catheterization that did not show obstructive CA

257 nts (mean 86 years, 46% female) referred for cardiac catheterization to evaluate AS also underwent tr

258 The Radiation Reduction During Cardiac Catheterization Using Real-Time Monitoring study

259 angina and coronary artery disease underwent cardiac catheterization via radial access and performed

260 During cardiac catheterization via radial access, they performe

261 down is not routinely required for pediatric cardiac catheterization via the carotid artery.

262 diac magnetic resonance imaging was 1.82, by cardiac catheterization was 1.65, and by echo was 1.7 L.

263 iovascular risk factors, the main reason for cardiac catheterization was an acute coronary syndrome (

264 n-based cohort of stable patients undergoing cardiac catheterization was assembled from April 1, 2006

265 Cardiac catheterization was common (71% and 51%), but pe

266 tive of a major adverse event or death after cardiac catheterization was derived in 70% of the cohort

267 were contacted to determine if postoperative cardiac catheterization was performed and examination of

268 Prestage II cardiac catheterization was performed at a mean age of 1

269 The benefits also persisted when cardiac catheterization was performed in control patient

270 A single cardiac catheterization was performed on each patient wi

271 ays, crude mortality for patients undergoing cardiac catheterization was slightly higher in New York

272 ac function assessed by echocardiography and cardiac catheterization was unaffected.

273 Cardiac catheterization was used as the standard of refe

274 Consecutive cases of ischemic stroke after cardiac catheterization were abstracted retrospectively

275 Exomes from 8,574 individuals referred for cardiac catheterization were analyzed.

276 Patients undergoing cardiac catheterization were enrolled and categorized ac

277 total of 66 cases of ischemic strokes after cardiac catheterization were identified over 3 to 4 year

278 onsecutive patients within IMPACT undergoing cardiac catheterization were identified.

279 h atrial septal defects (ASD) that underwent cardiac catheterization were included.

280 New York State, patients undergoing elective cardiac catheterization were significantly more likely t

281 age 58 +/- 8 years) referred for diagnostic cardiac catheterization were studied.

282 A total of 19,608 cardiac catheterizations were performed between January

283 t ventricular EF (echocardiography) and then cardiac catheterization, where left ventricular pressure

284 or coronary artery bypass surgery undergoing cardiac catheterization who had at least 1 SVG graft.

285 ACS patients undergoing cardiac catheterization with >or=1 nonobstructive native

286 ectively), both immediately before and after cardiac catheterization with coil and particle embolizat

287 tients with LGSAS and preserved EF underwent cardiac catheterization with comparison of hemodynamic m

288 thoracic echocardiography within 48 hours of cardiac catheterization with direct measurement of LAP.

289 Among patients undergoing cardiac catheterization with planned percutaneous corona

290 jects with HFpEF (N = 28) underwent invasive cardiac catheterization with simultaneous expired gas an

291 trial, subjects with HFpEF (n=26) underwent cardiac catheterization with simultaneous expired gas an

292 Animals underwent cardiac catheterization with VIR implantation via a tran

293 A subset underwent cardiac catheterizations with liver biopsy.

294 had CCTA and 32 (16%) who had MPI underwent cardiac catheterization within 1 year.

295 ection fraction of >or=45% underwent MPI and cardiac catheterization within 15 d.

296 e logistic regression to compare the odds of cardiac catheterization within 2 and 30 days of admissio

297 Tl/stress (99m)Tc dual-isotope gated MPS and cardiac catheterization within 3 mo.

298 associated with a 6% lower odds of receiving cardiac catheterization within 30 days (P=0.01) and a 14

299 e first 24 h and were less likely to undergo cardiac catheterization within 48 h.

300 ses additional serious risks associated with cardiac catheterization, yielding a non-radiogenic risk